0000000000376318

AUTHOR

Kamal Bouabdallah

showing 2 related works from this author

FIRST-LINE THERAPY OF T-CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION - FINAL RESULTS OF THE AATT STUDY

2019

OncologyCancer Researchmedicine.medical_specialtyConsolidation (soil)business.industryHematologyGeneral Medicinemedicine.disease03 medical and health sciences0302 clinical medicineFirst line therapyOncology030220 oncology & carcinogenesisInternal medicinemedicineT-cell lymphomaAutologous transplantationbusiness030215 immunologyHematological Oncology
researchProduct

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STU…

2019

Cancer Researchmedicine.medical_specialtyOncologybusiness.industryMedicinePhases of clinical researchHematologyGeneral MedicineSplenic marginal zone lymphomaRadiologybusinessmedicine.diseaseMinimal residual diseaseHematological Oncology
researchProduct